IC
RGNX icon

IEQ Capital’s Regenxbio RGNX Stock Holding History

IEQ Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
141,469
+1,830
+1% +$15.2K 0.01% 878
2026
Q1 		$1.17M Sell
139,639
-47,028
-25% -$494K 0.01% 972
2025
Q4 		$2.69M Buy
186,667
+27,863
+18% +$347K 0.01% 700
2025
Q3 		$1.53M Buy
158,804
+29,194
+23% +$258K ﹤0.01% 855
2025
Q2 		$1.06M Buy
129,610
+78,641
+154% +$658K 0.01% 837
2025
Q1 		$364K Buy
+50,969
New +$379K ﹤0.01% 1113

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

IEQ Capital's RGNX Position: Q2 2026 in Review

IEQ Capital increased its Regenxbio (RGNX) stake by 1.3% in Q2 2026, buying an estimated $15.2K and bringing the position to 141,469 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #878.

IEQ Capital first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.69M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • IEQ Capital held 141,469 shares of Regenxbio worth $1.69M as of Q2 2026.
  • IEQ Capital bought 1,830 Regenxbio shares in Q2 2026, an estimated $15.2K.
  • Regenxbio made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #878 holding.
  • IEQ Capital first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Regenxbio position peaked at $2.69M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.